Incidence of Febrile Neutropenia and Myelotoxicity of Chemotherapy: A Meta-Analysis of Biosimilar G-CSF Studies in Breast Cancer, Lung Cancer, and Non-Hodgkin’s Lymphoma

Publisher： Karger

E-ISSN： 2296-5262|32|10|599-604

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.10, 2009-09, pp. : 599-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G-CSF in the Prevention of Febrile Neutropenia in Chemotherapy in Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Burden of febrile neutropenia in the Netherlands

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 232-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin’s Lymphoma Patients Receiving Pegfilgrastim

By  

Acta Haematologica, Vol. 125, Iss. 3, 2010-11 ,pp. : 107-114

Karger

Access to resources Recommend Favorite

Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy

By Tan Sean P.   Chouaid C.   Hettler D.   Baud M.   Hejblum G.   Tilleul P.  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1455-1460

Informa Healthcare

Access to resources Recommend Favorite

Management of Febrile Neutropenia – a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer

By  

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 241-246

Karger

Access to resources Recommend Favorite